Should a loop ileostomy closure in rectal cancer patients be done during or after adjuvant chemotherapy?

Abstract Background and Objective The influence of ileostomy closure timing on surgical and oncologic outcome was investigated in patients with locally advanced rectal cancer receiving adjuvant chemotherapy after low anterior resection. Methods Consecutive patients diagnosed with T3‐4/N+ rectal cancer, treated by neoadjuvant chemoradiation and low anterior resection during 2000–2012 were retrospectively evaluated. Patients undergoing closure during adjuvant chemotherapy (Group A) were compared to patients undergoing closure after completing chemotherapy (Group B). Results A total of the 165 patients met inclusion criteria, of whom 104 received adjuvant chemotherapy (25 in Group A and 79 in Group B). The pathologic stage was higher in Group B ( P = 0.015). The rates of postoperative complications were similar (16% for Group A and 15% for Group B, P = 0.88), as was hospital stay (mean 5.78 days for Group A and 6.25 days for Group B, P = 0.7). There was no significant difference in recurrence rate and overall survival between the groups. Conclusions Referral to ileostomy closure in relation to adjuvant chemotherapy is influenced by pathologic stage. Early referral appears to be reserved to a small number of patients with lower pathologic stage. Timing of ileostomy closure does not change short‐ or long‐term results. J. Surg. Oncol. 2014 109:266–269 . © 2013 Wiley Periodicals, Inc.